Baxter Pharmaceutical Solutions 483, May 2016

Baxter Pharmaceutical Solutions 483, May 2016

Michele Forster FDA$119.00

FDA investigators audited the Baxter Pharmaceutical Solutions facility in Bloomington, IN, United States and issued inspectional observations (via FDA 483) on 12 May 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 12 May 2016
  • Location: Bloomington, United States